Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects
Condition: Respiratory DisordersInterventions: Drug: Reference Montelukast; Drug: Test 1 Montelukast; Drug: Test 2 MontelukastSponsor: GlaxoSmithKlineActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2014 Category: Research Source Type: clinical trials
Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects
Condition: Respiratory DisordersInterventions: Drug: Reference Montelukast; Drug: Test 1 Montelukast; Drug: Test 2 MontelukastSponsor: GlaxoSmithKlineActive, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2014 Category: Research Source Type: clinical trials
Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects
Condition: Respiratory DisordersInterventions: Drug: Reference Montelukast; Drug: Test 1 Montelukast; Drug: Test 2 MontelukastSponsor: GlaxoSmithKlineNot yet recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2014 Category: Research Source Type: clinical trials
A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
Condition: AsthmaInterventions: Other: Test1; Drug: lebrikizumab; Drug: montelukast [Singulair]; Other: placeboSponsor: Hoffmann-La RocheRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2014 Category: Research Source Type: clinical trials
